Astute Medical, Inc.
10
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
10.0%
1 terminated/withdrawn out of 10 trials
87.5%
+1.0% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Near Infrared Spectroscopy (St02)
Role: collaborator
Urine Sample Processing Study
Role: lead
A Urine Sample Collection Study in Apparently Healthy Adults and Adults With Chronic, Stable Morbidities
Role: lead
New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients
Role: collaborator
A Sample Collection Study to Validate the NEPHROCLEAR™ CCL14 Test
Role: lead
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Role: lead
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Role: lead
Specimen Stability Study
Role: lead
Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury
Role: lead
A Normal Donor Sample Collection Study in Healthy Adults
Role: lead
All 10 trials loaded